Skip to main content
AVACTA GROUP PLC logo

AVACTA GROUP PLC — Investor Relations & Filings

Ticker · AVCT ISIN · GB00BYYW9G87 LEI · 2138009U3EG31OPMGH36 IL Manufacturing
Open in API
Filings indexed 708 across all filing types
Latest filing 2020-04-09 Regulatory Filings
Country GB United Kingdom
Listing IL AVCT

About AVACTA GROUP PLC

https://avacta.com/

Avacta Group PLC is a clinical-stage biotechnology company developing targeted oncology drugs. The company's core technology is the proprietary pre|CISION® platform, a drug delivery system designed to improve the safety and efficacy of potent cancer therapies. The platform works by linking a peptide to a cancer drug, rendering it inactive in the bloodstream. The drug is precisely activated only within the tumor microenvironment by the Fibroblast Activation Protein (FAP) enzyme, which is abundant in many solid tumors. This approach aims to concentrate the active therapy at the tumor site, thereby reducing systemic toxicity and improving the therapeutic window for patients. The company is advancing a pipeline of peptide drug conjugates (PDCs) based on this platform.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1375 characters) and begins with an 'RNS Number' and the date, indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational notice rather than a comprehensive financial report (like 10-K or IR) or a standard corporate action announcement (like DIV or ER). Since it is a general regulatory announcement that doesn't fit the highly specific categories (AGM-R, 10-K, ER, etc.), the most appropriate classification is the general regulatory fallback category.
2020-04-09 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1358 characters) and begins with 'RNS Number : 4352J', indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Price Monitoring Extension' for an auction call period, which is a procedural update related to trading mechanics, not a core financial report (like 10-K, ER, or IR). Since it is a general regulatory announcement that doesn't fit the specific categories like DIRS, DIV, or MANG, the most appropriate classification is the general regulatory filing fallback category.
2020-04-09 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1375 characters) and begins with an 'RNS Number' and the issuer name, Avacta Group PLC. The content describes a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange, which is a specific, non-standard regulatory market announcement. Since it is a brief, specific market notice that doesn't fit the definitions for financial reports (10-K, IR, ER), management changes (MANG), or shareholder actions (DIV, DVA), the most appropriate classification is the general regulatory announcement fallback category, RNS.
2020-04-08 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1358 characters) and begins with 'RNS Number : 2547J' and mentions 'This information is provided by RNS, the news service of the London Stock Exchange.' The content discusses a 'Price Monitoring Extension' related to trading mechanics, which is a general regulatory announcement rather than a specific financial report (like 10-K, IR, or ER). Since it is explicitly identified as an RNS communication and deals with a procedural market event, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such announcements.
2020-04-08 English
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document is very short (1375 characters) and begins with an 'RNS Number', indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Second Price Monitoring Extension' related to trading activity, which is a specific, short-form regulatory update concerning market operations rather than a comprehensive financial report (like 10-K or IR) or a standard corporate action announcement (like DIV or ER). Since it is a general regulatory announcement that doesn't fit the highly specific categories like DIRS, DIV, or ER, the most appropriate classification is the general regulatory filing fallback category, RNS.
2020-04-08 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1358 characters) and begins with an 'RNS Number' and the issuer 'Avacta Group PLC', indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Price Monitoring Extension' related to auction call periods, which is a specific operational update regarding trading mechanics, not a core financial report (like 10-K, IR, or ER). Since it is a general regulatory announcement that doesn't fit the specific categories like DIRS, DIV, or MANG, the most appropriate fallback category is Regulatory Filings (RNS). The 'MENU VS MEAL' rule supports this, as it is a brief announcement rather than the full report itself.
2020-04-08 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.